Electroacupuncture modulates P300-mediated STAT6/PPARγ binding to promote M2 polarization of microglia following cerebral ischemic injury.

Researchers investigating electroacupuncture for stroke recovery have discovered how this treatment helps reduce brain inflammation and protect nerve cells. When someone experiences a stroke, immune cells in the brain called microglia can either help repair damage or make inflammation worse. This study found that electroacupuncture helps shift these cells into a helpful, anti-inflammatory state.

The research team used a mouse model of stroke, blocking blood flow to part of the brain to mimic what happens during a human ischemic stroke. They then treated some mice with electroacupuncture and compared them to untreated animals. The electroacupuncture group showed significantly better outcomes: improved blood flow to the brain, smaller areas of tissue damage, and better movement and walking ability.

The scientists discovered the mechanism behind these benefits. Electroacupuncture activates a protein called P300, which acts like a molecular coordinator. P300 helps two other proteins (STAT6 and PPARγ) work together more effectively to reprogram microglia into their healing mode. When researchers specifically blocked P300 in the brain, the beneficial effects of electroacupuncture disappeared, proving this protein's critical role.

This research is important because it reveals the biological pathway through which electroacupuncture provides neuroprotection after stroke. Understanding these mechanisms helps validate acupuncture as a legitimate therapeutic approach and may lead to more targeted treatments combining acupuncture with other therapies. For stroke patients considering complementary therapies, this adds scientific evidence supporting electroacupuncture's potential benefits in recovery. Anyone interested in pursuing electroacupuncture for stroke recovery should seek treatment from a licensed acupuncturist with experience in neurological conditions.

This preclinical study investigated the epigenetic mechanisms underlying electroacupuncture's neuroprotective effects following cerebral ischemia. Using a middle cerebral artery occlusion (MCAO) mouse model, researchers demonstrated that EA significantly improved cerebral blood flow, reduced infarct volume, and restored neurological function as measured by gait analysis, TTC staining, and HE staining.

The study's key mechanistic finding involves the transcriptional coactivator P300, which facilitates M2 polarization of microglia through enhanced assembly of the STAT6/PPARγ transcriptional complex. Using CD68 promoter-driven AAV with P300 shRNA knockdown technology, investigators demonstrated that local P300 depletion in the ischemic penumbra abolished EA-induced M2 microglial transition. Co-IP and ChIP-qPCR analyses confirmed that EA promotes functional recruitment of P300 to STAT6, stabilizing the STAT6/PPARγ complex on target gene promoters.

Clinical implications: This research provides mechanistic validation for EA's anti-neuroinflammatory effects post-stroke, identifying P300-mediated epigenetic regulation as a novel therapeutic target. The findings support EA's integration into post-stroke rehabilitation protocols and suggest potential synergy with pharmacological STAT6/PPARγ modulators.